SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

REAL-WORLD USE OF JAK INHIBITORS IN RHEUMATOLOGICAL PRACTICE IN SOUTH LONDON

Biddle, K; Buckeldee, O; Latheef, A; Al-Shakarchi, I; Sofat, N (2023) REAL-WORLD USE OF JAK INHIBITORS IN RHEUMATOLOGICAL PRACTICE IN SOUTH LONDON. In: EULAR 2023 European Congress of Rheumatology, ANNALS OF THE RHEUMATIC DISEASES, 31 May - 3 June 2023, Milan, Italy.
SGUL Authors: Sofat, Nidhi

[img]
Preview
PDF Accepted Version
Available under License ["licenses_description_publisher" not defined].

Download (194kB) | Preview
Item Type: Conference or Workshop Item (UNSPECIFIED)
Additional Information: This article has been accepted for publication in Annals of the Rheumatic Diseases, 2023 following peer review, and the Version of Record can be accessed online at https://doi.org/10.1136/annrheumdis-2023-eular.705. © Author(s) (or their employer(s)) 2023.
Keywords: Targeted synthetic drugs, Rheumatoid arthritis, Psoriatic arthritis, 1103 Clinical Sciences, 1107 Immunology, 1117 Public Health and Health Services, Arthritis & Rheumatology
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: ANNALS OF THE RHEUMATIC DISEASES
Article Number: AB0450
ISSN: 0003-4967
Dates:
DateEvent
30 May 2023Published
Publisher License: Publisher's own licence
Web of Science ID: WOS:001107398704487
URI: https://openaccess.sgul.ac.uk/id/eprint/116245
Publisher's version: https://doi.org/10.1136/annrheumdis-2023-eular.705

Actions (login required)

Edit Item Edit Item